513 related articles for article (PubMed ID: 20665445)
1. [Phenotypic characterization of pyrazinamide-resistant Mycobacterium tuberculosis isolated in Poland].
Napiórkowska A; Augustynowicz-Kopeć E; Zwolska Z
Pneumonol Alergol Pol; 2010; 78(4):256-62. PubMed ID: 20665445
[TBL] [Abstract][Full Text] [Related]
2. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
3. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].
Augustynowicz-Kopeć E; Zwolska Z; Jaworski A; Kostrzewa E; Klatt M; Swiderska A; Drozd I
Pneumonol Alergol Pol; 2002; 70(3-4):193-202. PubMed ID: 12271966
[TBL] [Abstract][Full Text] [Related]
4. [Investigation of pyrazinamide resistance in multidrug-resistant tuberculosis cases in Hospital of Pulmonary Diseases, Izmir, Turkey].
Senol G; Coşkun M; Gündüz AT; Biçmen C; Gayaf M; Ozsöz A
Mikrobiyol Bul; 2008 Oct; 42(4):591-7. PubMed ID: 19149080
[TBL] [Abstract][Full Text] [Related]
5. Genotypic characterization of pyrazinamide resistance in Mycobacterium tuberculosis isolated from Lusaka, Zambia.
Bwalya P; Yamaguchi T; Mulundu G; Nakajima C; Mbulo G; Solo ES; Fukushima Y; Kasakwa K; Suzuki Y
Tuberculosis (Edinb); 2018 Mar; 109():117-122. PubMed ID: 29559115
[TBL] [Abstract][Full Text] [Related]
6. First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia.
Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC
Int J Tuberc Lung Dis; 2012 Jun; 16(6):805-11. PubMed ID: 22390880
[TBL] [Abstract][Full Text] [Related]
7. Detection of multidrug resistance in Mycobacterium tuberculosis.
Sekiguchi J; Miyoshi-Akiyama T; Augustynowicz-Kopeć E; Zwolska Z; Kirikae F; Toyota E; Kobayashi I; Morita K; Kudo K; Kato S; Kuratsuji T; Mori T; Kirikae T
J Clin Microbiol; 2007 Jan; 45(1):179-92. PubMed ID: 17108078
[TBL] [Abstract][Full Text] [Related]
8. [Primary and acquired drug resistance of tuberculosis bacilli in Poland].
Zofia Z; Ewa AK; Magdalena K
Pneumonol Alergol Pol; 1999; 67(11-12):536-45. PubMed ID: 11057104
[TBL] [Abstract][Full Text] [Related]
9. Molecular identification of mutations associated with anti-tuberculosis drug resistance among strains of Mycobacterium tuberculosis.
Abbadi SH; Sameaa GA; Morlock G; Cooksey RC
Int J Infect Dis; 2009 Nov; 13(6):673-8. PubMed ID: 19138546
[TBL] [Abstract][Full Text] [Related]
10. Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam.
Hung NV; Ando H; Thuy TT; Kuwahara T; Hang NT; Sakurada S; Thuong PH; Lien LT; Keicho N
BMC Res Notes; 2013 Nov; 6():444. PubMed ID: 24188178
[TBL] [Abstract][Full Text] [Related]
11. Mycobacterium tuberculosis drug-resistance in previously treated patients in Ouagadougou, Burkina Faso.
Sangare L; Diande S; Kouanda S; Dingtoumda BI; Mourfou A; Ouedraogo F; Sawadogo I; Nebie B; Gueye A; Sawadogo LT; Traore AS
Ann Afr Med; 2010; 9(1):15-9. PubMed ID: 20418644
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterium tuberculosis genotypic diversity in pyrazinamide-resistant isolates of Iran.
Doustdar F; Khosravi AD; Farnia P
Microb Drug Resist; 2009 Dec; 15(4):251-6. PubMed ID: 19857130
[TBL] [Abstract][Full Text] [Related]
13. Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Turkey.
Yüksel P; Tansel O
New Microbiol; 2009 Apr; 32(2):153-8. PubMed ID: 19579692
[TBL] [Abstract][Full Text] [Related]
14. [A study of the bacteriophage-based assay for the detection of pyrazinamide resistance in Mycobacterium tuberculosis].
Ao JP; Chen JW; Hu ZY; Li JN; Wang J; Wang Q; Cui ZL; Zhang WH; Wong XH
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Sep; 29(9):625-8. PubMed ID: 17129472
[TBL] [Abstract][Full Text] [Related]
15. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
[TBL] [Abstract][Full Text] [Related]
16. [Pyrazinamide monoresistant Mycobacterium tuberculosis in Manisa region, Turkey].
Ozkütük N; Ecemiş T; Sürücüoğlu S
Mikrobiyol Bul; 2008 Oct; 42(4):585-90. PubMed ID: 19149079
[TBL] [Abstract][Full Text] [Related]
17. Pyrazinamide resistance in Mycobacterium tuberculosis arises after rifampicin and fluoroquinolone resistance.
Alame-Emane AK; Xu P; Pierre-Audigier C; Cadet-Daniel V; Shen X; Sraouia M; Siawaya JF; Takiff H; Gao Q; Gicquel B
Int J Tuberc Lung Dis; 2015 Jun; 19(6):679-84. PubMed ID: 25946359
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of katG Ser315 substitution and rpoB mutations in isoniazid-resistant Mycobacterium tuberculosis isolates from Brazil.
Höfling CC; Pavan EM; Giampaglia CM; Ferrazoli L; Aily DC; de Albuquerque DM; Ramos MC
Int J Tuberc Lung Dis; 2005 Jan; 9(1):87-93. PubMed ID: 15675556
[TBL] [Abstract][Full Text] [Related]
19. [Characteristics of pncA gene in multidrug-resistant Mycobacterium tuberculosis isolates and its correlation with drug resistance to pyrazinamide].
Hong CY; Wang F; Gui J; Liu XL
Zhonghua Yu Fang Yi Xue Za Zhi; 2012 May; 46(5):436-9. PubMed ID: 22883731
[TBL] [Abstract][Full Text] [Related]
20. Characterization of pyrazinamide resistance in consecutive multidrug-resistant
Mansjo M; Werngren J; Hoffner S
Int J Mycobacteriol; 2017; 6(2):156-161. PubMed ID: 28559517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
